Two presenters will be exploring effective targeting to healthcare professional audiences from two different perspectives. Scott Weintraub will discuss the value in segmenting the physician audience by geography, and R.J. Lewis will explain how informed targeting to authenticated prescribers can be done effectively online.

Healthcare providers agree that the toughest challenge to treating patients is neither the effectiveness of their medication, nor issues with access and affordability. It's getting the patient to take their medicine as prescribed. And for the brand marketer, the new growth frontier resides on the sloping shoulders of patient adherence.

Pharmaceutical marketers are grappling with both the exciting potential and daunting challenges associated with Big Data. By focusing on the wealth of data captured from non-personal promotions and inbound and outbound prescriber interactions, marketers can apply advanced analytics to create a 360 view of their customer and deliver relevant, personalized offers.

Audience will learn how regional marketing can benefit your brand's position; how to make regional marketing simple and executable; and the value of a district level driver analysis and how this can become the foundation of regional marketing intelligence

Healthcare consumers are flocking to the social Web to post about their experiences with a given disease and the treatments they hope will help fight it. State-of-the-art search software is available to capture and process these conversations, meaning pharma has access to a wealth of consumer dialogues. Yet 'listening' to patients doesn't mean we're hearing them. Jeff Greene and Susan Eno Collins will present findings from a mining effort of thousands of online conversations about rheumatoid arthritis, along with the implications for brands across every disease category.

Healthcare consumers are flocking to the social Web to post about their experiences with a given disease and the treatments they hope will help fight it. State-of-the-art search software is available to capture and process these conversations, meaning pharma has access to a wealth of consumer dialogues. Yet 'listening' to patients doesn't mean we're hearing them. Jeff Greene and Susan Eno Collins will present findings from a mining effort of thousands of online conversations about rheumatoid arthritis, along with the implications for brands across every disease category.

As the healthcare landscape becomes increasingly digital, and pharma marketers integrate e-tactics with offline activities, there is a need to better understand how integrated strategies impact ROI. In this special webcast event, we will explore how a new technology platform called CurametRx is closing the loop on Rx analysis by capturing behavior metrics at the sales representative, medical office, patient, and pharmacy level to provide a 360° view of patient engagement journeys.

With the FDA Internet and social media hearings now complete, many Pharma marketers are left trying to answer the question, "what am I supposed to do TODAY?" Formal guidance may not be issued until 2011, yet marketers still have the need to execute digital programs responsibly.

Join Everyday Health and the IAB for a first-hand look at the issues surrounding the FDA's request for guidance on digital guidelines. From the five questions posed by the FDA to the industry's response at the hearings on November 12-13, Ben Wolin, CEO and Co-Founder of the largest online health property, and Mike Zaneis, VP of Public Affairs of the IAB, will provide a full wrap up, analysis and next steps for the industry. The FDA's last public meeting on online advertising was in1996, so this is an important issue with great implications.

As the world moves into a digital environment--so are physicians. HCPs are typically among the first to adopt new technology as it applies to their profession, including the use of mobile.